Archive: 24/10/2013

FDA advisers unanimously back J&J hepatitis C drug

An experimental hepatitis C drug from Johnson & Johnson has won unanimous support from government experts who say the medication should be approved to treat patients infected with the liver-destroying virus.

page 2 from 9